Tuesday - October 6, 2026
Kirkland Advises Trilantic-Backed SOFIE Biosciences on Acquisition by GE HealthCare
October 05, 2026
CHICAGO, Illinois, Oct. 5 [Category: BizLaw/Legal] -- Kirkland and Ellis, a law firm, issued the following news release:

* * *

Kirkland Advises Trilantic-Backed SOFIE Biosciences on Acquisition by GE HealthCare

*

Kirkland & Ellis advised Trilantic-backed SOFIE Biosciences, a leading U.S.-based CMO for PET radiopharmaceuticals, on a definitive agreement to be acquired by GE HealthCare (Nasdaq: GEHC) for a purchase price of $945 million paid . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Click here for more information about our products